Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
Condition: Gastroenteritis Interventions: Combination Product: GSK's liquid oral live attenuated HRV; Combination Product: PCV-free liquid formulation of GSK's oral live attenuated HRV Sponsor: GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
Condition: Gastroenteritis Interventions: Combination Product: GSK's liquid oral live attenuated HRV; Combination Product: PCV-free liquid formulation of GSK's oral live attenuated HRV Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants
Condition: Gastroenteritis Interventions: Biological: Placebo; Biological: HIL-214 Sponsor: HilleVax Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials